Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

NCT01087788 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

409

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

BIOLOGICAL: CZP 200 mg Q2W
BIOLOGICAL: CZP 400 mg Q4W
OTHER: Placebo

Sponsor

UCB BIOSCIENCES GmbH